GLP-1 Weight Loss Injections at Synergy MedSpa MD

  Semaglutide is a GLP-1 receptor agonist, while Tirzepatide is a dual agonist that activates both GLP-1 and GIP receptors. That means Tirzepatide may have an enhanced effect on appetite control and insulin regulation, leading to even greater weight loss in some patients.

  Both are highly effective, but clinical studies suggest that Tirzepatide can lead to up to 20% total body weight loss, while Semaglutide often results in up to 15% weight loss. Results vary based on your body and consistency with your program.

Both Semaglutide and Tirzepatide are administered as a once-weekly injection. At Synergy MedSpa MD, we provide these in-office during your weekly check-ins to ensure you're progressing safely and comfortably. We adjust your dosage weekly as needed, so you won’t experience unnecessary side effects—our goal is to support steady, sustainable weight loss with minimal discomfort.

A: Yes.

• Semaglutide is the active ingredient in Wegovy® and Ozempic®.
• Tirzepatide is found in Mounjaro® and Zepbound™.

We use compounded versions of both to make them accessible, affordable, and available for in-office use under medical supervision.

During your initial consultation, we’ll evaluate your goals, health history, and weight loss timeline to determine whether Semaglutide or Tirzepatide is the better fit for your journey.

Not at all. While GLP-1 medications like Semaglutide and Tirzepatide are powerful tools, they’re just one part of our comprehensive weight loss offerings. At Synergy MedSpa MD, we also offer customized non-injection weight loss plans that include weekly coaching, nutrition guidance, fat-burning lipotropic and B12 injections, and EMS fitness training. We’ll help you choose the best path based on your preferences, goals, and health needs.